Skip to main content

Diabetes Therapy

Ausgabe 3/2019

Inhalt (33 Artikel)

Open Access Review

Cardiovascular Risk in Type 1 Diabetes Mellitus

Jonathan Schofield, Jan Ho, Handrean Soran

Open Access Review

Euthymia in Diabetes: Clinical Evidence and Practice-Based Opinion from an International Expert Group

Sanjay Kalra, A. K. Das, M. P. Baruah, A. G. Unnikrishnan, Arundhati Dasgupta, Parag Shah, Rakesh Sahay, Rishi Shukla, Sambit Das, Mangesh Tiwaskar, G. Vijayakumar, Manoj Chawla, Fatimah Eliana, Ketut Suastika, Abbas Orabi, Aly Ahmed Abdul Rahim, Andrew Uloko, Roberta Lamptey, Nancy Ngugi, Silver Bahendeka, Abdurezak Ahmed Abdela, Fariduddin Mohammed, Mohammed Faruque Pathan, Muhammed Hafizur Rahman, Faria Afsana, Shajada Selim, Muaz Moosa, Moosa Murad, Pradeep Krishna Shreshtha, Dina Shreshtha, Mimi Giri, Wiam Hussain, Ahmed Al-Ani, Kaushik Ramaiya, Surender Singh, Syed Abbas Raza, Than Than Aye, Chaminda Garusinghe, Dimuthu Muthukuda, Muditha Weerakkody, Shyaminda Kahandawa, Charlotte Bavuma, Sundeep Ruder, Koy Vanny, Manish Khanolkar, Leszek Czupryniak

Open Access Review

Use of Insulin Glargine 100 U/mL for the Treatment of Type 2 Diabetes Mellitus in East Asians: A Review

Takahisa Hirose, Ching-Chu Chen, Kyu Jeung Ahn, Jacek Kiljański

Open Access Review

A View Beyond HbA1c: Role of Continuous Glucose Monitoring

Haleh Chehregosha, Mohammad E. Khamseh, Mojtaba Malek, Farhad Hosseinpanah, Faramarz Ismail-Beigi

Open Access Original Research

Establishing Expert, Multi-Disciplinary, Peer-Reviewed Consensus to Lead a Paradigm Shift in Optimal Blood Glucose Management

Douglas A. Robertson, Richard A. Chudleigh, Simon D. Gwynn, Carol Jairam, Kaushal Kansagra, Naresh Kanumilli, Adam Lester-George, Charlotte McMurray, Timothy C. Warren

Open Access Original Research

Downregulation of T-Cell Transcription Factors in Adult Latent Autoimmune Diabetes with High-Titer Glutamic Acid Decaroxylase Antibody

Xia Wang, Lin Yang, Ying Cheng, Huiying Liang, Jingping Hu, Peilin Zheng, Gan Huang, Zhiguang Zhou

Open Access Original Research

Real-Life Management and Effectiveness of Insulin Pump with or Without Continuous Glucose Monitoring in Adults with Type 1 Diabetes

Clara Viñals, Carmen Quirós, Marga Giménez, Ignacio Conget

Open Access Original Research

Effectiveness and Tolerability of Vildagliptin and the Single Pill Combination of Vildagliptin and Metformin in “Real-World” Management of Type 2 Diabetes Mellitus: The G-FORCE Study

Luc Van Gaal, Michel P. Hermans, Evis Daci, Kris Denhaerynck, Lut De Meester, Karen MacDonald, Ivo Abraham, Stefaan Vancayzeele, Michael Maris

Open Access Original Research

Real-World Effectiveness and Safety of Lixisenatide as Add-On to Oral Antidiabetic Drugs as Part of Routine Clinical Practice in Bulgaria: LIXODAR Study

Nataliya Temelkova, Stefka Vladeva, Aleksi Delchev, Kalina Ivanova, Yoanna Gerasimova-Zheleva, Tsvetodara Kuneva, Veselina Pehlivanova, Plamen Popivanov

Open Access Original Research

Laboratory Computer-Based Interventions for Better Adherence to Guidelines in the Diagnosis and Monitoring of Type 2 Diabetes

Maria Salinas, Maite López-Garrigós, Emilio Flores, Javier Lugo, Carlos Leiva-Salinas, Beatriz Massa-Dominguez, Antonio Gómez-Gras, Norma Iranzo, Alejandro Canals-Baeza, Jose L. López-Blasco, Esperanza Gonzalez-Alvaro, Ramon de Juan Francés, Jordi Gisbert-Segura, Rosario Oliver-Ros, Alberto Asencio-Aznar, Juan J. Ballester-Baixaulí, Ballester-Baixaulí Pardo-Tomas

Open Access Original Research

Effect of Once-Weekly Dulaglutide on Glucose Levels in Japanese Patients with Type 2 Diabetes: Findings from a Phase 4, Randomized Controlled Trial

Megumi Inoue, Masanari Shiramoto, Tomonori Oura, Risa Nasu, Masako Nakano, Masakazu Takeuchi

Open Access Original Research

Efficacy and Safety of Fast-Acting Insulin Aspart in People with Type 1 Diabetes Using Carbohydrate Counting: A Post Hoc Analysis of Two Randomised Controlled Trials

Ludger Rose, Takashi Kadowaki, Thomas R. Pieber, Kristine Buchholtz, Magnus Ekelund, Anders Gorst-Rasmussen, Athena Philis-Tsimikas

Open Access Original Research

Efficacy and Safety of Basal Analog Regimens in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Ting Hong, Jing Lu, Pengzi Zhang, Zhou Zhang, Qianyue Xu, Yunguang Li, Nan Cui, Ambar Grijalva, Erin M. Murray, Michael A. del Aguila, Yan Bi

Open Access Original Research

GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data

Victoria Divino, Kristina S. Boye, Jeremie Lebrec, Mitch DeKoven, Kirsi Norrbacka

Open Access Original Research

Real-World Experience of Adding Metformin in Pregnant Women with Type 1 Diabetes in a Chinese Population: A Retrospective Cohort

Fan Ping, Mingqun Deng, Xiao Zhai, Yingna Song, Xinhua Xiao

Open Access Original Research

Real-World Data on the Incidence of Macrovascular Complications in Japanese Patients with Type 2 Diabetes: The Sitagliptin Registration Type 2 Diabetes-Juntendo Collaborating Project

Hirotoshi Ohmura, Tomoya Mita, Joe Matsuoka, Shuko Nojiri, Yuji Nishizaki, Hirotaka Watada, Hiroyuki Daida

Open Access Original Research

Change in HbA1c Across the Baseline HbA1c Range in Type 2 Diabetes Patients Receiving Once-Weekly Dulaglutide Versus Other Incretin Agents

Raffaella Gentilella, Irene Romera, Claudia Nicolay, Raffaella Buzzetti, Luis Alberto Vázquez, Giorgio Sesti

Open Access Brief Report

Hypoglycemia Abrogates the Vascular Endothelial Protective Effect of Exenatide in Type 2 Diabetes Mellitus

Keiichi Torimoto, Yosuke Okada, Yoshiya Tanaka

Open Access Brief Report

Combined Effects of Energy Intake and Physical Activity on Obesity in Japanese Patients with Type 2 Diabetes (JDDM 50): A Cross-Sectional Study

Mariko Hatta, Kazuya Fujihara, Sakiko Yoshizawa Morikawa, Yasutake Takeda, Dai Ishii, Chika Horikawa, Mitsutoshi Kato, Hiroki Yokoyama, Yoshio Kurihara, Koichi Iwasaki, Kazuhiro Miyazawa, Katsuya Yamazaki, Shiro Tanaka, Hiroshi Maegawa, Hirohito Sone

Open Access Case Series

Acquired Hemophilia A Associated with Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus: A Single-Center Case Series in Japan

Satoshi Yamasaki, Masanori Kadowaki, Takashi Jiromaru, Ken Takase, Hiromi Iwasaki

Open Access Study Protocol

Study Protocol for the Effects of Artificial Intelligence (AI)-Supported Automated Nutritional Intervention on Glycemic Control in Patients with Type 2 Diabetes Mellitus

Rie Oka, Akihiro Nomura, Ayaka Yasugi, Mitsuhiro Kometani, Yuko Gondoh, Kenichi Yoshimura, Takashi Yoneda

Open Access Letter

The Relationship Between Sleep and Quality of Life in Type 1 Diabetes Patients

Ellen M. S. Xerfan, Jane Tomimori, Rachel G. Albuquerque, Sergio Tufik, Monica L. Andersen

Open Access Correction

Correction to: Evaluating the User Performance and Experience with a Re-Engineered 4mm × 32G Pen Needle: A Randomized Trial with Similar Length/Gauge Needles

Shahista Whooley, Toby Briskin, Michael A. Gibney, Lydia R. Blank, Julie Berube, Brian K. Pflug

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.